A digital platform is aimed at making specific innovations and technological solutions, produced by the academic and research community, more accessible to private companies. It is a service for automatically downloading, synchronizing, sorting and displaying information from large scientific platforms such as Academia.edu, Google Scholar, or Researchers Gate to the platform EmpowerHR4Inno. Platform initially focus on priority sectors, food, health tourism, horizontal IT priority and nationally produced solutions with a tendency for further development. The following information can be found:
  • Course library with sub-content WoS published, results, other solutions, and digital tools and HR models;
  • Set of features that allow sending newsletters to users who sign up as interested in a particular group of news feeds.
Walter de Gruyter GmbH
Risk factors for adverse drug reactions associated with clopidogrel therapy
Abstract This study aimed to investigate the possible influence of genetic and non-genetic factors on the incidence of clopidogrel adverse drug reactions (ADRs) in cardiology patients, including the most important CYP2C19 alleles, namely *2 and *17, as well as compliance, dose, drug interactions, and clinical factors. A total of 102 clopidogrel-treated adult Caucasian patients hospitalized at the Cardiology Department of the Clinical Center of Montenegro were enrolled in the study....
Download 2022 Ivan Radosavljevic , Natasa Djordjevic , Majda Sahman , Snezana Mugosa , Zoran Todorovic
Walter de Gruyter GmbH
ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
Abstract Clopidogrel is an antiplatelet drug that displays significant interindividual variability in treatment response. Its bioavailability depends on the function of P-glycoprotein (P-gp), which is coded by a highly polymorphic ABCB1 gene. Thus, the aim of this study was to investigate the effect of ABCB1 genetic polymorphism on clopidogrel efficacy and safety and to determine the frequency distribution of its most common single nucleotide polymorphisms (SNPs) in 106 Montenegrin...
Download 2021 Natasa Djordjevic , Majda Sahman-Zaimovic , Snezana Mugosa , Zoran Todorovic , Jelena Cukic
National Library of Serbia
Adverse drug reactions associated with sunitinib therapy: Characteristics and risk factors
Background/Aim. Kidney tumors account for 2?3% of all tumors. Renal cell carcinoma (RCC) is the tenth most common malignancy. Sunitinib is used as the first treatment line in patients with a good and intermediate prognosis. The aim of this study was to analyze the risk factors, frequency, and adverse drug reactions (ADRs) of sunitinib in patients with metastatic RCC. Methods. The retrospective study included 170 patients treated at the Clinic for Oncology of the Clinical Center of Montenegro, Urology...
Download 2021 Majda Sahman-Zaimovic , Nevenka Lukovac-Janjic , Zoran Dzamic , Snezana Mugosa
  • Previous
  • 1 (current)
  • Next
Partners
Subscribe to repository